(Q37213081)

19 August 2017

1 reference

title

Candidate biomarkers for the detection of coronary plaque destabilization and rupture (English)

1 reference

19 August 2017

0 references

Sotirios Tsimikas

1 reference

19 August 2017

Anand Prasad

1 reference

19 August 2017

publication date

1 August 2008

1 reference

Current Atherosclerosis Reports

19 August 2017

1 reference

inferred from page(s)

published in

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

309-317

1 reference

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0048-5

Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0048-5

Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0048-5

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0048-5

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-008-0048-5

Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial

21 January 2018

1 reference

12 December 2020

Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study

1 reference

12 December 2020

Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titrati

1 reference

12 December 2020

Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice

1 reference

12 December 2020

Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease

1 reference

12 December 2020

Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study

1 reference

12 December 2020

Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study

1 reference

12 December 2020

Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study

1 reference

12 December 2020

Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease

1 reference

12 December 2020

Oxidized LDL in carotid plaques and plasma associates with plaque instability

1 reference

12 December 2020

Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis

1 reference

12 December 2020

Present and future biochemical markers for detection of acute coronary syndrome

1 reference

12 December 2020

Soluble CD40 Ligand in Acute Coronary Syndromes

1 reference

12 December 2020

Towards understanding acute destabilization of vulnerable atherosclerotic plaques

1 reference

12 December 2020

Impact of oxidized low density lipoprotein on vascular cells

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients

1 reference

12 December 2020

Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein

1 reference

12 December 2020

Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase

1 reference

12 December 2020

Soluble CD40L: risk prediction after acute coronary syndromes

1 reference

12 December 2020

Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability

1 reference

12 December 2020

Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes

1 reference

12 December 2020

Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes

1 reference

12 December 2020

Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization

1 reference

12 December 2020

Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

1 reference

12 December 2020

Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study

1 reference

12 December 2020

Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME).

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infar

1 reference

12 December 2020

Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque

1 reference

12 December 2020

Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation

1 reference

12 December 2020

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

12 December 2020

Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

1 reference

12 December 2020

Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study.

1 reference

12 December 2020

Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I Elevation

1 reference

12 December 2020

Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction

1 reference

12 December 2020

CD40 signaling and plaque instability

1 reference

12 December 2020

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes

1 reference

12 December 2020

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

1 reference

12 December 2020

Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris

1 reference

12 December 2020

Soluble CD40L and cardiovascular risk in women

1 reference

12 December 2020

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

1 reference

12 December 2020

Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study.

1 reference

12 December 2020

Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling

1 reference

12 December 2020

High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial

1 reference

12 December 2020

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes

1 reference

12 December 2020

Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis

1 reference

12 December 2020

Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment

1 reference

12 December 2020

Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease

1 reference

12 December 2020

Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina

1 reference

12 December 2020

Prognostic value of placental growth factor in patients with acute chest pain

1 reference

12 December 2020

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

1 reference

12 December 2020

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes

1 reference

12 December 2020

Biomarkers of atherosclerotic plaque instability and rupture

1 reference

12 December 2020

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions

1 reference

12 December 2020

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

1 reference

12 December 2020

Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies.

1 reference

12 December 2020

Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study

1 reference

12 December 2020

IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10

1 reference

12 December 2020

Metalloproteinases and vulnerable atherosclerotic plaques

1 reference

12 December 2020

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

1 reference

12 December 2020

10.1007/S11883-008-0048-5

Identifiers

DOI

1 reference

19 August 2017

1 reference